Merck | MRK - EPS Earnings Per Share


Merck reported $2.49 in EPS Earnings Per Share for its fiscal quarter ending in September of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2026 2.49 2.28 2.58 Oct/29
FY2026Q2 Jun/2026 -0.13 1.77 2.13 Aug/04
FY2026Q1 Mar/2026 -1.28 -1.55 2.22 Apr/30
FY2025Q4 Dec/2025 2.04 2.05 1.72 Feb/03
FY2025Q3 Sep/2025 2.58 2.37 1.57 Oct/30




Eps Change Date
AbbVie USD 3.82 0.17 Sep/2026
Abbott USD 0.53 0.78 Sep/2026
ALKERMES USD 0.09 0.09 Sep/2026
Amgen USD 6.45 0.16 Sep/2026
AstraZeneca USD 2.79 0.16 Sep/2026
Biogen USD 2.62 0.98 Sep/2026
Bristol-Myers Squibb USD 1.35 0.69 Sep/2026
Coherus Biosciences USD -0.43 0.06 Dec/2025
Drreddys Laboratories INR 11.1 11.04 Sep/2026
Eli Lilly USD 7.48 0.9 Sep/2026
Gilead Sciences USD 2.55 9.3 Sep/2026
GlaxoSmithKline GBP 0.55 0.04 Sep/2026
Glaxosmithkline GBP 0.76 0.14 Sep/2026
J&J USD 2.7 0.2 Sep/2026
Medtronic USD 1.45 0.1 Jun/2026
Merck USD 2.49 2.62 Sep/2026
Novartis USD 2.46 0.05 Sep/2026
Novartis USD 0.63 1.36 Sep/2026
Novo Nordisk DKK 4.74 6.17 Jun/2026
Pacira USD 0.7 0.03 Sep/2026
Perrigo USD 0.6 0.1 Sep/2026
Pfizer USD 0.87 0.1 Sep/2026
Phibro Animal Health USD 0.78 0.1 Dec/2025
Prestige Brands USD 0.98 0.25 Jun/2026
Regeneron Pharmaceuticals USD 20.07 5.78 Sep/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sanofi EUR 3.55 1.46 Sep/2026
Sanofi EUR 0.14 2.02 Jun/2026
United Therapeutics USD 5.71 1.56 Sep/2026
Zoetis USD 1.75 0.12 Sep/2026